go-v.orgdoi

Exclusive patent, know-how and process license to research, develop, use, import, make, have made, sell, offer and sublicense products in the field of genetically modified bacteriophages using synthetic biology for human therapeutics to treat bacterial infections associated with acute and chronic wounds, to treat Pseudomonas aeruginosa lung infections, and to treat infections of Clostridium difficile, using licensor's 'UltraVector,' 'LEAP,' DNA and RNA MOD engineering, protein engineering, transcription control chemistry, genome engineering and cell system engineering technology and platforms.

RoyaltyStat · RoyaltyStat Library · 2019

  • DOI 10.34675/l28126
  • Publisher OpenAlex
  • Type article
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

RoyaltyStat Library · OpenAlex · article · 2019

Crossref supplies no abstract for this record; none is generated here.

Open the resolved locator · 10.34675/l28126

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:41 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://royaltystat.com/
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.